199 related articles for article (PubMed ID: 35021279)
1. Efficacy of the Ketogenic Diet for Pediatric Epilepsy According to the Presence of Detectable Somatic mTOR Pathway Mutations in the Brain.
Ko A; Sim NS; Choi HS; Yang D; Kim SH; Lee JS; Kim DS; Lee JH; Kim HD; Kang HC
J Clin Neurol; 2022 Jan; 18(1):71-78. PubMed ID: 35021279
[TBL] [Abstract][Full Text] [Related]
2. mTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes.
Krochmalnek E; Accogli A; St-Onge J; Addour-Boudrahem N; Prakash G; Kim SH; Brunette-Clement T; Alhajaj G; Mougharbel L; Bruneau E; Myers KA; Dubeau F; Karamchandani J; Farmer JP; Atkinson J; Hall J; Chantal Poulin C; Rosenblatt B; Lafond-Lapalme J; Weil A; Fallet-Bianco C; Albrecht S; Sonenberg N; Riviere JB; Dudley RW; Srour M
Neurol Genet; 2023 Dec; 9(6):e200103. PubMed ID: 37900581
[TBL] [Abstract][Full Text] [Related]
3. Somatic variants in new candidate genes identified in focal cortical dysplasia type II.
Zhang Z; Gao K; Liu Q; Zhou J; Li X; Lang N; Liu M; Wang T; Zhang J; Wang H; Dong Y; Ji T; Wang S; Liu X; Jiang Y; Cai L; Wu Y
Epilepsia; 2020 Apr; 61(4):667-678. PubMed ID: 32216069
[TBL] [Abstract][Full Text] [Related]
4. Germline and somatic mutations in the
Møller RS; Weckhuysen S; Chipaux M; Marsan E; Taly V; Bebin EM; Hiatt SM; Prokop JW; Bowling KM; Mei D; Conti V; de la Grange P; Ferrand-Sorbets S; Dorfmüller G; Lambrecq V; Larsen LH; Leguern E; Guerrini R; Rubboli G; Cooper GM; Baulac S
Neurol Genet; 2016 Dec; 2(6):e118. PubMed ID: 27830187
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic methods and treatment options for focal cortical dysplasia.
Guerrini R; Duchowny M; Jayakar P; Krsek P; Kahane P; Tassi L; Melani F; Polster T; Andre VM; Cepeda C; Krueger DA; Cross JH; Spreafico R; Cosottini M; Gotman J; Chassoux F; Ryvlin P; Bartolomei F; Bernasconi A; Stefan H; Miller I; Devaux B; Najm I; Giordano F; Vonck K; Barba C; Blumcke I
Epilepsia; 2015 Nov; 56(11):1669-86. PubMed ID: 26434565
[TBL] [Abstract][Full Text] [Related]
6. mTOR pathway activation in focal cortical dysplasia.
Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
[TBL] [Abstract][Full Text] [Related]
7. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.
Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N
Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084
[TBL] [Abstract][Full Text] [Related]
8. Identification of genetic characteristics in pediatric epilepsy with focal cortical dysplasia type 2 using deep whole-exome sequencing.
Xu Y; Zhao R; Wang M; Wang XH; Wang Y; Li H; Ma YY; Wu BB; Zhou YF
Mol Genet Genomic Med; 2022 Dec; 10(12):e2086. PubMed ID: 36342087
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive treatment options for focal cortical dysplasia.
Wang TT; Zhou D
Exp Ther Med; 2016 May; 11(5):1537-1541. PubMed ID: 27168769
[TBL] [Abstract][Full Text] [Related]
10. Epilepsy in the mTORopathies: opportunities for precision medicine.
Moloney PB; Cavalleri GL; Delanty N
Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
[TBL] [Abstract][Full Text] [Related]
11. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
[TBL] [Abstract][Full Text] [Related]
12. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
[TBL] [Abstract][Full Text] [Related]
13. Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy.
Marsan E; Baulac S
Neuropathol Appl Neurobiol; 2018 Feb; 44(1):6-17. PubMed ID: 29359340
[TBL] [Abstract][Full Text] [Related]
14. The role of somatic mutational events in the pathogenesis of epilepsy.
Iffland PH; Crino PB
Curr Opin Neurol; 2019 Apr; 32(2):191-197. PubMed ID: 30762606
[TBL] [Abstract][Full Text] [Related]
15. Ketogenic diet and other dietary treatments for epilepsy.
Martin K; Jackson CF; Levy RG; Cooper PN
Cochrane Database Syst Rev; 2016 Feb; 2():CD001903. PubMed ID: 26859528
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
[TBL] [Abstract][Full Text] [Related]
17. Genomic and Epigenetic Advances in Focal Cortical Dysplasia Types I and II: A Scoping Review.
Jesus-Ribeiro J; Pires LM; Melo JD; Ribeiro IP; Rebelo O; Sales F; Freire A; Melo JB
Front Neurosci; 2020; 14():580357. PubMed ID: 33551717
[No Abstract] [Full Text] [Related]
18. Brain Somatic Variant in Ras-Like Small GTPase
Xu H; Gao K; Liu Q; Wang T; Zhang Z; Cai L; Wu Y; Jiang Y
Front Behav Neurosci; 2022; 16():919485. PubMed ID: 35846790
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations rather than viral infection classify focal cortical dysplasia type II as mTORopathy.
Blümcke I; Sarnat HB
Curr Opin Neurol; 2016 Jun; 29(3):388-95. PubMed ID: 26840044
[TBL] [Abstract][Full Text] [Related]
20. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
McDaniel SS; Rensing NR; Thio LL; Yamada KA; Wong M
Epilepsia; 2011 Mar; 52(3):e7-11. PubMed ID: 21371020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
